N-(4-(4-Fluorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)butanamide

Catalog No. :
ACCHRE263
CAS No. :
795282-68-7
Molecular Formula :
C17H15FN2OS2
Molecular Weight :
346.45

IUPAC Name:N-(4-(4-fluorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)butanamide

N-(4-(4-Fluorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)butanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$293.00Login to see priceIn stockInquiry
250mg98%$496.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(4-Fluorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)butanamide
IUPAC NameN-(4-(4-fluorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)butanamide
Molecular FormulaC17H15FN2OS2
Molecular Weight346.45
SMILESFC1=CC=C(C2=CSC(NC(CCCC3=CC=CS3)=O)=N2)C=C1
InChI KeyVSGDPFBBEZFQBN-UHFFFAOYSA-N
Synonym2-Thiophenebutanamide, N-[4-(4-fluorophenyl)-2-thiazolyl]-;N-(4-(4-Fluorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)butanamide;WAY-637936
CAS No.795282-68-7
PubChem CID2444234

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACCHRE263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBOW457 route compound structure diagram
    ACDBOW45777815-14-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHRE263 route product structure diagram
    ACCHRE263795282-68-7 In Stock
Inquiry

2. ACCHRE263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBOW457 route compound structure diagram
    ACDBOW45777815-14-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHRE263 route product structure diagram
    ACCHRE263795282-68-7 In Stock
Inquiry

Comments (0)